Advanced search×

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy.

Mary Amanda MA Dew, Ellen M EM Whyte, Eric J EJ Lenze, Patricia R PR Houck, Benoit H BH Mulsant, Bruce G BG Pollock, Jacqueline A JA Stack, Salem S Bensasi, and Charles F CF Reynolds

Am J Psychiatry 164(6):892-9 (2007) PMID 17541048

Few data are available concerning the utility of augmentation in late-life depression treatment. The authors examined likelihood, speed, and predictors of recovery in older adults receiving augmentation pharmacotherapy after inadequate response to standardized treatment with paroxetine plus interpersonal psychotherapy.

DOI: 10.1176/appi.ajp.164.6.892
Version: za2963e q8za8 q8zb1 q8zc9 q8zdf q8ze6 q8zf0 q8zge
View PDF

Similar articles you may find interesting…

  1. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of done...
    Charles F CF Reynolds, Meryl A MA Butters, ... Steven T ST DeKosky

    Arch Gen Psychiatry 68(1):51-60 (2011) PMID 21199965 PMCID PMC3076045

    Cognitive impairment in late-life depression is a core feature of the illness. To test whether donepezil hydrochloride and antidepressant therapy is superior to placebo and antidepressant therapy in improving cognitive performance and instrumental activities of daily living and in reducing recurrenc...
    View PDF
  2. Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residents.
    Bruce G Pollock and Benoit H Mulsant

    CMAJ 183(7):778-9 (2011) PMID 21444612

  3. Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residents.
    Bruce G BG Pollock and Benoit H BH Mulsant

    CMAJ 183(7):778-9 (2011) PMID 21444612

    View PDF